Fintel reports that on November 13, 2025, HC Wainwright & Co. maintained coverage of PDS Biotechnology (NasdaqCM:PDSB) with a ...
4don MSN
PDS Biotech outlines trial protocol amendment for accelerated PFS endpoint in HPV16-positive cancer
Get key insights from PDS Biotech’s Q3 2025 earnings call, including regulatory updates for PDS0101 in HPV16+ cancer and financial highlights.
PDS Biotechnology Corp (PDSB) reports promising trial results and strategic collaborations, despite financial hurdles and trial amendments.
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...
Analysts expect PDS Biotechnology to report an earnings per share (EPS) of $-0.20. PDS Biotechnology bulls will hope to hear ...
The Trentonian on MSN
Non-Public B South Boys Soccer: PDS holds on to defeat Moorestown Friends
It is the second consecutive season the Panthers have reached the Non-Public B South final, actually falling in a shootout at ...
The Trentonian on MSN
Non-Public B South Boys Soccer: PDS shut out by Ranney School
The Princeton Day School varsity boys’ soccer team’s run to the NJSIAA Non-Public B South title game ended without a trophy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback